Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Morphological alterations and redox changes associated with hepatic warm ischemia-reperfusion injury.

Jawad R, D'souza M, Selenius LA, Lundgren MW, Danielsson O, Nowak G, Björnstedt M, Isaksson B.

World J Hepatol. 2017 Dec 8;9(34):1261-1269. doi: 10.4254/wjh.v9.i34.1261.

2.

Histopathological evaluation of liver fibrosis and cirrhosis regression.

Lo RC, Kim H.

Clin Mol Hepatol. 2017 Dec;23(4):302-307. doi: 10.3350/cmh.2017.0078. Epub 2017 Dec 20. Review.

3.
4.

A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.

Boege Y, Malehmir M, Healy ME, Bettermann K, Lorentzen A, Vucur M, Ahuja AK, Böhm F, Mertens JC, Shimizu Y, Frick L, Remouchamps C, Mutreja K, Kähne T, Sundaravinayagam D, Wolf MJ, Rehrauer H, Koppe C, Speicher T, Padrissa-Altés S, Maire R, Schattenberg JM, Jeong JS, Liu L, Zwirner S, Boger R, Hüser N, Davis RJ, Müllhaupt B, Moch H, Schulze-Bergkamen H, Clavien PA, Werner S, Borsig L, Luther SA, Jost PJ, Weinlich R, Unger K, Behrens A, Hillert L, Dillon C, Di Virgilio M, Wallach D, Dejardin E, Zender L, Naumann M, Walczak H, Green DR, Lopes M, Lavrik I, Luedde T, Heikenwalder M, Weber A.

Cancer Cell. 2017 Sep 11;32(3):342-359.e10. doi: 10.1016/j.ccell.2017.08.010.

5.

Ultrastructural Characteristics of Rat Hepatic Oval Cells and Their Intercellular Contacts in the Model of Biliary Fibrosis: New Insights into Experimental Liver Fibrogenesis.

Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM, Daniluk U, Sobaniec P, Sendrowski K, Daniluk J, Reszec J, Debek W.

Gastroenterol Res Pract. 2017;2017:2721547. doi: 10.1155/2017/2721547. Epub 2017 Jul 9.

6.

Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis.

Li XM, Chen Z, Xiao EH, Shang QL, Ma C.

World J Gastroenterol. 2017 May 7;23(17):3133-3141. doi: 10.3748/wjg.v23.i17.3133.

7.

A New Oleanolic Acid Derivative against CCl₄-Induced Hepatic Fibrosis in Rats.

Xiang H, Han Y, Zhang Y, Yan W, Xu B, Chu F, Xie T, Jia M, Yan M, Zhao R, Wang P, Lei H.

Int J Mol Sci. 2017 Mar 6;18(3). pii: E553. doi: 10.3390/ijms18030553.

8.

Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis.

Wang J, Malik N, Yin M, Smyrk TC, Czaja AJ, Ehman RL, Venkatesh SK.

World J Gastroenterol. 2017 Feb 7;23(5):859-868. doi: 10.3748/wjg.v23.i5.859.

9.

Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin.

Ballester-Ferré MP, Martínez F, Garcia-Gimeno N, Mora F, Serra MA.

World J Hepatol. 2017 Jan 28;9(3):161-166. doi: 10.4254/wjh.v9.i3.161.

10.

Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging.

Müller A, Hochrath K, Stroeder J, Hittatiya K, Schneider G, Lammert F, Buecker A, Fries P.

Biomed Res Int. 2017;2017:8720367. doi: 10.1155/2017/8720367. Epub 2017 Jan 18.

11.

Unusual Case of an Alcoholic with Liver Injury from Sulfasalazine Use.

Masood U, Sharma A, Nijjar S, Krenzer B.

J Basic Clin Pharm. 2016 Dec;8(1):38-39. doi: 10.4103/0976-0105.195126.

12.

Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.

Stewart SH, Reuben A, Anton RF.

Alcohol Alcohol. 2017 Jan;52(1):24-28. doi: 10.1093/alcalc/agw069. Epub 2016 Oct 7.

13.

Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.

Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, Chen J; Guideline Committee.

World J Gastroenterol. 2016 Nov 14;22(42):9279-9287. Review.

14.

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.

Aiken T, Garber A, Thomas D, Hamon N, Lopez R, Konjeti R, McCullough A, Zein N, Fung J, Askar M, John BV.

PLoS One. 2016 Nov 22;11(11):e0166998. doi: 10.1371/journal.pone.0166998. eCollection 2016.

15.

Novel Approach for Evaluation of Bacteroides fragilis Protective Role against Bartonella henselae Liver Damage in Immunocompromised Murine Model.

Pagliuca C, Cicatiello AG, Colicchio R, Greco A, Cerciello R, Auletta L, Albanese S, Scaglione E, Pagliarulo C, Pastore G, Mansueto G, Brunetti A, Avallone B, Salvatore P.

Front Microbiol. 2016 Nov 7;7:1750. eCollection 2016.

16.

Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study.

Russo P, Magee JC, Anders RA, Bove KE, Chung C, Cummings OW, Finegold MJ, Finn LS, Kim GE, Lovell MA, Magid MS, Melin-Aldana H, Ranganathan S, Shehata BM, Wang LL, White FV, Chen Z, Spino C; Childhood Liver Disease Research Network (ChiLDReN).

Am J Surg Pathol. 2016 Dec;40(12):1601-1615.

17.

Evaluation of liver fibrosis: "Something old, something new…".

Almpanis Z, Demonakou M, Tiniakos D.

Ann Gastroenterol. 2016 Oct-Dec;29(4):445-453. Epub 2016 May 27. Review.

18.

Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.

Sansoè G, Aragno M, Mastrocola R, Mengozzi G, Novo E, Parola M.

PLoS One. 2016 Sep 16;11(9):e0162644. doi: 10.1371/journal.pone.0162644. eCollection 2016.

20.

Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial.

Abbas Z, Memon MS, Umer MA, Abbas M, Shazi L.

World J Hepatol. 2016 May 18;8(14):625-31. doi: 10.4254/wjh.v8.i14.625.

Supplemental Content

Support Center